Drug

Cetuximab-IRDye 800CW clinical trials

studies test it: 10
open now: 2
in phase 3: 0
first study started: 2015

Keep track of what changes. Save the Cetuximab-IRDye 800CW studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Cetuximab-IRDye800: 8
Cetuximab-IRDye800CW: 3
Cetuximab-IRDye 800CW: 2

Studies by the year they started

10 studies that test it; most in 2016 (2)

Studies that test Cetuximab-IRDye 800CW, by start year
Year	Studies
2015	1
2016	2
2017	1
2019	1
2020	1
2022	1
2023	2
2024	1

By phase

A phase 1/2 study counts in both.

Phase 1: 7
Phase 2: 5

What it is tested for

Each study’s main condition, where its own words name it.

Squamous Cell Carcinoma of Head and Neck: 2
Penile Neoplasms: 1
Rectal Neoplasms: 1
Lung Neoplasms: 1
Glioblastoma: 1
Neoplasms: 1
Head and Neck Neoplasms: 1
Esophageal Neoplasms: 1

Who runs them

Industry 0 · Other 10

University Medical Center Groningen (5) · Eben Rosenthal (3) · University of Turin, Italy (1) · Fifth Affiliated Hospital, Sun Yat-Sen University (1)

Often tested with

Tested in the same studies.

Cetuximab (2)

Studies

Open first, then newest update. How each study uses Cetuximab-IRDye 800CW is read from its arms, and is right about nine times in ten.